Search

everythinglearnresearchcommunity

for

Search:↓

Ginsenoside F2 may help prevent hair loss and promote hair growth better than finasteride.

FFA's causes may include environmental triggers and genetic factors.

Modified frameworks with stearic acid enhance drug delivery and promote hair growth.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Baricitinib and tofacitinib have different safety patterns in treating alopecia areata.

Finasteride reduces alcohol withdrawal severity in male mice but increases it in female mice.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Finasteride, a hair loss drug, is linked to increased suicidal thoughts, particularly when used for hair loss.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Certain amino acids in 5AR1 and 5AR2 are crucial for binding and resistance to Finasteride.

The document's conclusion cannot be provided because the document is not accessible or understandable.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Certain changes in the KAP6-1 gene affect the thickness and length of cashmere goat fibers.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Finasteride helps 83% of men maintain or increase hair count.

Finasteride use can cause depression-like behavior in male rats.

The method accurately measures dichloromethane and chloroform in finasteride.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

The new topical product combined with finasteride significantly increased hair thickness without side effects.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Lack of Crif1 in hair follicle stem cells slows down hair growth in mice.

Finasteride may negatively affect male fertility.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

A stable and simple finasteride suspension was developed that retains over 94.3% of its concentration for up to 90 days and doesn't significantly increase occupational exposure, but safety measures are still advised.

TQC shows promise for better hair regrowth in treating hair loss.